Australian Super Pty LTD Abbott Laboratories Transaction History

Australian Super Pty LTD

$19.6 Billion
Q3 2024

A detailed history of Australian Super Pty LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Australian Super Pty LTD holds 26,521 shares of ABT stock, worth $3.03 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

26,521

Previous 2,030,340 98.69%

Holding current value

$3.03 Million

Previous $211 Million 98.57%

% of portfolio

0.02%

Previous 1.24%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$100.07 - $118.13 $201 Million - $237 Million	-2,003,819 Reduced 98.69%	26,521 $3.02 Million
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $10.1 Million - $11.3 Million	-100,379 Reduced 4.71%	2,030,340 $211 Million
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $99.7 Million - $110 Million	-910,431 Reduced 29.94%	2,130,719 $242 Million
Q4 2023 Jan 16, 2024	SELL	$90.19 - $110.4 $34.2 Million - $41.8 Million	-378,761 Reduced 11.08%	3,041,150 $335 Million
Q3 2023 Oct 27, 2023	BUY	$95.53 - $114.62 $30.7 Million - $36.9 Million	321,620 Added 10.38%	3,419,911 $331 Million
Q2 2023 Jul 28, 2023	BUY	$100.78 - $112.29 $35.5 Million - $39.6 Million	352,268 Added 12.83%	3,098,291 $338 Million
Q1 2023 Apr 21, 2023	BUY	$96.86 - $114.01 $8.88 Million - $10.5 Million	91,720 Added 3.46%	2,746,023 $278 Million
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $67.7 Million - $79.4 Million	-712,358 Reduced 21.16%	2,654,303 $291 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $47.3 Million - $54.8 Million	488,831 Added 16.99%	3,366,661 $326 Million
Q2 2022 Jul 13, 2022	BUY	$102.07 - $123.37 $23.2 Million - $28 Million	226,918 Added 8.56%	2,877,830 $313 Million
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $7.49 Million - $9.13 Million	-65,665 Reduced 2.42%	2,650,912 $314 Million
Q4 2021 Jan 24, 2022	SELL	$115.53 - $141.46 $2.56 Million - $3.13 Million	-22,123 Reduced 0.81%	2,716,577 $369 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $12.4 Million - $13.7 Million	105,998 Added 4.03%	2,738,700 $324 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $236 Million - $278 Million	2,234,307 Added 560.83%	2,632,702 $305 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $61.3 Million - $72.2 Million	-563,078 Reduced 58.56%	398,395 $47.7 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $11.9 Million - $12.9 Million	-113,008 Reduced 10.52%	961,473 $105 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $35.9 Million - $43.6 Million	391,846 Added 57.4%	1,074,481 $117 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $2.43 Million - $3.11 Million	-31,782 Reduced 4.45%	682,635 $62.4 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $7.92 Million - $11.6 Million	-126,080 Reduced 15.0%	714,417 $56.4 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $15.7 Million - $17.5 Million	199,796 Added 31.18%	840,497 $73 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $38.5 Million - $41.7 Million	470,297 Added 275.99%	640,701 $53.6 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $12.4 Million - $14.5 Million	170,404 New	170,404 $14.3 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $24.5 Million - $27 Million	-425,000 Closed	0 $0
Q4 2017 Jan 18, 2018	SELL	$53.68 - $57.47 $3.33 Million - $3.56 Million	-62,000 Reduced 12.73%	425,000 $24.3 Million
Q3 2017 Dec 15, 2017	BUY	$48.06 - $53.64 $23.4 Million - $26.1 Million	487,000	487,000 $26 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Australian Super Pty LTD with notifications on news.

Account

Australian Super Pty LTD Abbott Laboratories Transaction History